Abich Financial Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Abich Financial Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$13.7K	Buy	+95	New	+$13K	﹤0.01%	440

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Abich Financial Wealth Management's IBB Position: Q3 2025 in Review

Abich Financial Wealth Management opened a new position in iShares Biotechnology ETF (IBB) in Q3 2025: 95 shares worth $13.7K. The stake represents ﹤0.01% of the portfolio and ranks #440 among its holdings.

803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

Abich Financial Wealth Management held 95 shares of iShares Biotechnology ETF worth $13.7K as of Q3 2025.
iShares Biotechnology ETF was a new Abich Financial Wealth Management position in Q3 2025.
iShares Biotechnology ETF made up ﹤0.01% of Abich Financial Wealth Management's portfolio in Q3 2025, its #440 holding.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Abich Financial Wealth Management's 13F filing for Q3 2025, filed 6 Nov 2025.